Bristol-Myers Squibb Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance
July 25, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.18, $0.12 better than the analyst estimate of $1.06. Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.20-$4.30, versus the consensus of... More
